The Problem with Sepsis is…
Focusing on the Coda Sepsis agenda & drawing actions from WHO Sepsis Resolution, this panel session will combine sepsis survivors and families, clinicians and researchers to better define the human cost of sepsis. This session will formally launch the design thinking process towards community generated sepsis actions for Coda 2022.
Professor Carol Hodgson PhD FACP PT is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre at Monash University. She has developed and led international Phase II and III trials to test early interventions to improve long-term outcomes and the quality of survival.
She leads grants (> $15M) for international, randomised trials and a binational registry.
Her work as a specialist ICU physiotherapist leading clinical research in Australia and New Zealand has led to a paradigm shift in the treatment of ICU patients, especially rehabilitation practices.
She has over 100 publications in this field and experience developing international guidelines for mechanical ventilation, early mobilisation and the management of sepsis.@chodgsonANZICRC
Simon Finfer is an intensive care clinician and researcher in Sydney, a Professorial Fellow at The George Institute for Global Health, Adjunct Professor at the University of New South Wales, Senior Staff Specialist at Royal North Shore Hospital and Director of Intensive Care at the Sydney Adventist Hospital. Simon was a founding member and is a past-Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, past chair of the Council of the International Sepsis Forum, and current Vice President of the Global Sepsis Alliance. Simon was appointed an Officer (AO) in the Order of Australia in the Queen’s Birthday Honours List June 2020 for “distinguished service to intensive care medicine, to medical research and education, and to global health institutes”.@icuresearch
Ron Daniels is an NHS Consultant in Intensive Care, based in Birmingham, U.K. He’s also Executive Director of the UK Sepsis Trust and sits on the Executive Board of the Global Sepsis Alliance. In 2016 he was awarded the British Empire Medal for services to patients. Ron’s expertise lies in translational medicine and leadership. He leads the team driving dissemination of the Sepsis 6 treatment pathway and is part of the team responsible for much of the policy and media engagement around sepsis in the U.K. and elsewhere, including the adoption of the 2017 Resolution on Sepsis by the WHO. At home, Ron’s worked with the NHS over the last 5 years to ensure that, in England, more than 80% of patients presenting with suspected sepsis now receive appropriate antimicrobials rapidly. He’s ever mindful of the perceived conflict, and the synergies and need for collaboration, with the antimicrobial stewardship agenda.